• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

阿尔茨海默病和帕金森病的神经病理学基础。

Neuropathological substrates of Alzheimer's disease and Parkinson's disease.

作者信息

Jellinger K

机构信息

Ludwig Boltzmann Institute of Clinical Neurobiology, Lainz Hospital, Vienna, Austria.

出版信息

J Neural Transm Suppl. 1987;24:109-29.

PMID:3316494
Abstract

The pathology of Alzheimer's disease (AD) and Parkinson's disease (PD) is characterized by degeneration of certain vulnerable neuronal populations that display several types of cytoskeletal abnormalities (Alzheimer-type lesions and Lewy bodies, respectively). These may serve as diagnostic markers, although they can be found in both types of disorders and, less frequently, in brains of normal aged individuals. AD pathology shows a preponderance for hippocampal, neocortical, and forebrain cholinergic systems; the hallmark of PD is damage to the nigrostriatal dopaminergic system. Both disorders show frequent involvement of subcortical projection systems that can be similar in quality and distribution, with similar multiple neuromediator dysfunction. The results of morphometric studies of some subcortical nuclei in AD and PD are reported and related with neurochemical data. In addition to classical forms of AD and PD, both types of lesions can coexist suggesting an increased risk of PD in patients with AD and vice versa. The basis for an association between the two disorders is unknown. Many AD cases with signs of PD have additional PD pathology, while cortical Alzheimer lesions may be seen in demented PD patients. However, dementia in PD does not imply coexistent cortical AD pathology; prominent subcortical lesions alone, or in combination with cortical AD pathology, may occur. AD and PD may show some differences in the primary locus of degenerative changes in specific cortical and subcortical neuronal systems, but the causative factors, mutual relations, and relative contributions to the clinical syndromes remain to be elucidated.

摘要

阿尔茨海默病(AD)和帕金森病(PD)的病理学特征是某些易损神经元群体发生退化,分别表现出几种类型的细胞骨架异常(分别为阿尔茨海默型病变和路易小体)。这些异常可作为诊断标志物,尽管它们在这两种疾病中均可发现,且在正常老年人的大脑中较少见。AD病理学表现为海马、新皮质和前脑胆碱能系统受累为主;PD的标志是黑质纹状体多巴胺能系统受损。这两种疾病均常累及皮质下投射系统,其性质和分布可能相似,伴有相似的多种神经介质功能障碍。本文报告了AD和PD中一些皮质下核的形态学研究结果,并将其与神经化学数据相关联。除了AD和PD的经典形式外,这两种病变可能并存,提示AD患者患PD的风险增加,反之亦然。这两种疾病之间关联的基础尚不清楚。许多有PD体征的AD病例存在额外的PD病理学改变,而痴呆的PD患者可能出现皮质阿尔茨海默病变。然而,PD中的痴呆并不意味着并存皮质AD病理学改变;单独的显著皮质下病变或与皮质AD病理学改变并存的情况都可能发生。AD和PD在特定皮质和皮质下神经元系统退化变化的主要部位可能存在一些差异,但致病因素、相互关系以及对临床综合征的相对贡献仍有待阐明。

相似文献

1
Neuropathological substrates of Alzheimer's disease and Parkinson's disease.阿尔茨海默病和帕金森病的神经病理学基础。
J Neural Transm Suppl. 1987;24:109-29.
2
Alpha-synuclein pathology in Parkinson's and Alzheimer's disease brain: incidence and topographic distribution--a pilot study.帕金森病和阿尔茨海默病大脑中的α-突触核蛋白病理学:发病率和拓扑分布——一项初步研究。
Acta Neuropathol. 2003 Sep;106(3):191-201. doi: 10.1007/s00401-003-0725-y. Epub 2003 Jul 5.
3
New developments in the pathology of Parkinson's disease.帕金森病病理学的新进展。
Adv Neurol. 1990;53:1-16.
4
Neuropathological distinction between Parkinson's dementia and Parkinson's plus Alzheimer's disease.帕金森病痴呆与帕金森叠加型阿尔茨海默病的神经病理学区别。
Ann Neurol. 1989 Sep;26(3):309-20. doi: 10.1002/ana.410260302.
5
Can Alzheimer's type pathology influence the clinical phenotype of Parkinson's disease?阿尔茨海默病类型的病理改变会影响帕金森病的临床表型吗?
Acta Neurol Scand. 2005 Jun;111(6):353-9. doi: 10.1111/j.1600-0404.2005.00411.x.
6
Pathological basis for dementia in elderly patients with idiopathic Parkinson's disease.老年特发性帕金森病患者痴呆的病理基础
Eur Neurol. 1988;28 Suppl 1:29-35.
7
Amyloid beta-peptide and the dementia of Parkinson's disease.淀粉样β肽与帕金森病性痴呆
Mov Disord. 1996 Nov;11(6):647-53. doi: 10.1002/mds.870110609.
8
The morphological basis of mental dysfunction in Parkinson's disease.帕金森病精神功能障碍的形态学基础。
J Neurol Sci. 2006 Oct 25;248(1-2):167-72. doi: 10.1016/j.jns.2006.05.002. Epub 2006 Jun 23.
9
A modern hypothesis: The distinct pathologies of dementia associated with Parkinson's disease versus Alzheimer's disease.一种现代假说:帕金森病与阿尔茨海默病相关痴呆的不同病理表现。
Dement Geriatr Cogn Disord. 2008;25(4):301-8. doi: 10.1159/000119104. Epub 2008 Mar 3.
10
Neuronal loss in the substantia nigra in patients with Alzheimer's disease and Parkinson's disease in relation to extrapyramidal symptoms and dementia.阿尔茨海默病和帕金森病患者黑质中的神经元丢失与锥体外系症状和痴呆的关系。
Prog Clin Biol Res. 1989;317:325-32.

引用本文的文献

1
Proteinopathy and Longitudinal Cognitive Decline in Parkinson Disease.帕金森病中的蛋白构象病与纵向认知衰退。
Neurology. 2022 Jul 5;99(1):e66-e76. doi: 10.1212/WNL.0000000000200344. Epub 2022 Apr 13.
2
Lipids Nutrients in Parkinson and Alzheimer's Diseases: Cell Death and Cytoprotection.脂类与帕金森病和阿尔茨海默病中的营养:细胞死亡与细胞保护。
Int J Mol Sci. 2020 Apr 3;21(7):2501. doi: 10.3390/ijms21072501.
3
The Sources of Reactive Oxygen Species and Its Possible Role in the Pathogenesis of Parkinson's Disease.活性氧物种的来源及其在帕金森病发病机制中的可能作用。
Parkinsons Dis. 2018 Sep 2;2018:9163040. doi: 10.1155/2018/9163040. eCollection 2018.
4
Management of Psychosis in Parkinson's Disease: Emphasizing Clinical Subtypes and Pathophysiological Mechanisms of the Condition.帕金森病精神病的管理:强调该病症的临床亚型和病理生理机制
Parkinsons Dis. 2017;2017:3256542. doi: 10.1155/2017/3256542. Epub 2017 Sep 12.
5
The cholinergic basal forebrain in Lewy body dementia and Alzheimer's disease.路易体痴呆和阿尔茨海默病中的胆碱能基底前脑。
J Neurol. 2015 Feb;262(2):479-80. doi: 10.1007/s00415-014-7610-6. Epub 2014 Dec 12.
6
Allopregnanolone increases the number of dopaminergic neurons in substantia nigra of a triple transgenic mouse model of Alzheimer's disease.雄烷二醇可增加阿尔茨海默病三转基因小鼠模型黑质多巴胺能神经元的数量。
Curr Alzheimer Res. 2012 May;9(4):473-80. doi: 10.2174/156720512800492567.
7
Does Alzheimer's disease begin in the brainstem?阿尔茨海默病是否始于脑干?
Neuropathol Appl Neurobiol. 2009 Dec;35(6):532-54. doi: 10.1111/j.1365-2990.2009.01038.x. Epub 2009 Aug 4.
8
Frequency of the apolipoprotein E epsilon 4 allele in a case-control study of early onset Parkinson's disease.早发性帕金森病病例对照研究中载脂蛋白Eε4等位基因的频率
J Neurol Neurosurg Psychiatry. 1996 Oct;61(4):347-51. doi: 10.1136/jnnp.61.4.347.
9
Ganglioglioma with neurofibrillary tangles (NFTs): neoplastic NFTs share antigenic determinants with NFTs of Alzheimer's disease.
Acta Neuropathol. 1995;89(5):451-3. doi: 10.1007/BF00307651.
10
The pedunculopontine nucleus in Parkinson's disease, progressive supranuclear palsy and Alzheimer's disease.帕金森病、进行性核上性麻痹和阿尔茨海默病中的脚桥核
J Neurol Neurosurg Psychiatry. 1988 Apr;51(4):540-3. doi: 10.1136/jnnp.51.4.540.